| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 5.63e-11 | 14 | 106 | 6 | GO:0005130 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 1.82e-09 | 23 | 106 | 6 | GO:0034235 | |
| GeneOntologyMolecularFunction | filamin binding | 8.34e-09 | 29 | 106 | 6 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 8.34e-09 | 29 | 106 | 6 | GO:0035325 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 2.31e-08 | 34 | 106 | 6 | GO:0015125 | |
| GeneOntologyMolecularFunction | glycolipid binding | 2.25e-07 | 49 | 106 | 6 | GO:0051861 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 1.93e-06 | 70 | 106 | 6 | GO:1901618 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 2.48e-06 | 73 | 106 | 6 | GO:0170055 | |
| GeneOntologyMolecularFunction | calmodulin binding | 3.80e-06 | 230 | 106 | 9 | GO:0005516 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 3.96e-06 | 173 | 106 | 8 | GO:0070851 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 8.42e-06 | 90 | 106 | 6 | GO:0008028 | |
| GeneOntologyMolecularFunction | cytokine receptor binding | 8.85e-06 | 324 | 106 | 10 | GO:0005126 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 1.47e-05 | 149 | 106 | 7 | GO:1990782 | |
| GeneOntologyMolecularFunction | actin binding | HIP1 PSG1 MYO5B PSG2 PSG3 PSG6 PSG11 DBN1 FSCN2 PPP1R18 PSG8 | 4.83e-05 | 479 | 106 | 11 | GO:0003779 |
| GeneOntologyMolecularFunction | phosphatase binding | 8.28e-05 | 264 | 106 | 8 | GO:0019902 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 8.47e-05 | 196 | 106 | 7 | GO:0005319 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.19e-04 | 207 | 106 | 7 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.23e-04 | 208 | 106 | 7 | GO:0005342 | |
| GeneOntologyMolecularFunction | phospholipid binding | HIP1 PSG1 PSG2 PSG3 PSG6 PSG11 ADGRB1 PLA2G4B PSG8 VPS13B CPNE7 | 1.59e-04 | 548 | 106 | 11 | GO:0005543 |
| GeneOntologyMolecularFunction | dioxygenase activity | 1.76e-04 | 98 | 106 | 5 | GO:0051213 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 2.83e-04 | 316 | 106 | 8 | GO:0035091 | |
| GeneOntologyMolecularFunction | 2-oxoglutarate-dependent dioxygenase activity | 3.96e-04 | 65 | 106 | 4 | GO:0016706 | |
| GeneOntologyMolecularFunction | vascular endothelial growth factor binding | 4.13e-04 | 6 | 106 | 2 | GO:0038085 | |
| GeneOntologyMolecularFunction | vascular endothelial growth factor receptor activity | 5.76e-04 | 7 | 106 | 2 | GO:0005021 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 8.98e-04 | 210 | 106 | 6 | GO:0019903 | |
| GeneOntologyMolecularFunction | glutamate receptor binding | 9.12e-04 | 81 | 106 | 4 | GO:0035254 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 9.64e-04 | 293 | 106 | 7 | GO:0008514 | |
| GeneOntologyMolecularFunction | protein heterodimerization activity | 1.28e-03 | 398 | 106 | 8 | GO:0046982 | |
| GeneOntologyMolecularFunction | co-SMAD binding | 1.78e-03 | 12 | 106 | 2 | GO:0070410 | |
| GeneOntologyMolecularFunction | calcium:monoatomic cation antiporter activity | 2.10e-03 | 13 | 106 | 2 | GO:0015368 | |
| GeneOntologyMolecularFunction | phosphatidate phosphatase activity | 2.44e-03 | 14 | 106 | 2 | GO:0008195 | |
| GeneOntologyMolecularFunction | ionotropic glutamate receptor binding | 2.66e-03 | 52 | 106 | 3 | GO:0035255 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 3.12e-03 | 55 | 106 | 3 | GO:0042974 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 2.67e-11 | 24 | 107 | 7 | GO:2001214 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 4.91e-11 | 14 | 107 | 6 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 6.76e-11 | 27 | 107 | 7 | GO:0070344 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 7.39e-11 | 45 | 107 | 8 | GO:0048521 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 8.15e-11 | 15 | 107 | 6 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 8.15e-11 | 15 | 107 | 6 | GO:1903387 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 8.15e-11 | 15 | 107 | 6 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 8.15e-11 | 15 | 107 | 6 | GO:0002859 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 1.18e-10 | 29 | 107 | 7 | GO:2001212 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 1.30e-10 | 16 | 107 | 6 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 2.00e-10 | 17 | 107 | 6 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 2.00e-10 | 17 | 107 | 6 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 2.00e-10 | 17 | 107 | 6 | GO:0038158 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 2.51e-10 | 32 | 107 | 7 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 2.98e-10 | 18 | 107 | 6 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 3.17e-10 | 33 | 107 | 7 | GO:2000252 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 6.18e-10 | 20 | 107 | 6 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 8.62e-10 | 21 | 107 | 6 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 8.62e-10 | 21 | 107 | 6 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 8.62e-10 | 21 | 107 | 6 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 1.18e-09 | 22 | 107 | 6 | GO:0030853 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 1.59e-09 | 23 | 107 | 6 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.59e-09 | 23 | 107 | 6 | GO:0002858 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 2.11e-09 | 24 | 107 | 6 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 2.11e-09 | 24 | 107 | 6 | GO:0002420 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 2.76e-09 | 25 | 107 | 6 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 2.76e-09 | 25 | 107 | 6 | GO:0002423 | |
| GeneOntologyBiologicalProcess | behavior | PSG1 PSG2 PSG3 PSG6 PSG11 GATM BCHE DBN1 ACSS2 ITGA5 SLC8A3 FIG4 NETO1 VPS13A UBA6 UBR3 PSG8 FTO CSMD1 VPS13B GPRC5B | 5.12e-09 | 891 | 107 | 21 | GO:0007610 |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 5.81e-09 | 28 | 107 | 6 | GO:0034111 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 1.12e-08 | 31 | 107 | 6 | GO:0010544 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 1.37e-08 | 32 | 107 | 6 | GO:0045779 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 1.37e-08 | 32 | 107 | 6 | GO:0060312 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 1.67e-08 | 33 | 107 | 6 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 2.02e-08 | 34 | 107 | 6 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 2.02e-08 | 34 | 107 | 6 | GO:0046851 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 2.43e-08 | 35 | 107 | 6 | GO:1901142 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 2.87e-08 | 61 | 107 | 7 | GO:0060259 | |
| GeneOntologyBiologicalProcess | endothelium development | 3.75e-08 | 182 | 107 | 10 | GO:0003158 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 4.08e-08 | 38 | 107 | 6 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 4.80e-08 | 39 | 107 | 6 | GO:0045717 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 5.63e-08 | 40 | 107 | 6 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 6.56e-08 | 41 | 107 | 6 | GO:0002716 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 7.40e-08 | 105 | 107 | 8 | GO:0042267 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 7.63e-08 | 42 | 107 | 6 | GO:0090330 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-1 production | 9.26e-08 | 72 | 107 | 7 | GO:0032692 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immunity | 9.91e-08 | 109 | 107 | 8 | GO:0002228 | |
| GeneOntologyBiologicalProcess | regulation of ERK1 and ERK2 cascade | PRAMEF10 PSG1 PSG2 PSG3 PSG6 PRAMEF19 PSG11 DENND2B NRP1 PTPN6 KDR PSG8 SLC30A10 | 1.01e-07 | 385 | 107 | 13 | GO:0070372 |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 1.02e-07 | 73 | 107 | 7 | GO:0042304 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 1.34e-07 | 46 | 107 | 6 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 1.34e-07 | 46 | 107 | 6 | GO:0072574 | |
| GeneOntologyBiologicalProcess | endothelial cell differentiation | 1.37e-07 | 158 | 107 | 9 | GO:0045446 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 1.53e-07 | 47 | 107 | 6 | GO:0001911 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 1.53e-07 | 47 | 107 | 6 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 1.53e-07 | 47 | 107 | 6 | GO:0034104 | |
| GeneOntologyBiologicalProcess | vasculogenesis | 1.84e-07 | 118 | 107 | 8 | GO:0001570 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 1.97e-07 | 49 | 107 | 6 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 1.97e-07 | 49 | 107 | 6 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 2.23e-07 | 50 | 107 | 6 | GO:0002834 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 2.49e-07 | 83 | 107 | 7 | GO:0002707 | |
| GeneOntologyBiologicalProcess | ERK1 and ERK2 cascade | PRAMEF10 PSG1 PSG2 PSG3 PSG6 PRAMEF19 PSG11 DENND2B NRP1 PTPN6 KDR PSG8 SLC30A10 | 2.61e-07 | 418 | 107 | 13 | GO:0070371 |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 2.84e-07 | 52 | 107 | 6 | GO:0031342 | |
| GeneOntologyBiologicalProcess | regulation of sprouting angiogenesis | 2.94e-07 | 85 | 107 | 7 | GO:1903670 | |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 3.18e-07 | 86 | 107 | 7 | GO:0042058 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 3.19e-07 | 53 | 107 | 6 | GO:0034110 | |
| GeneOntologyBiologicalProcess | regulation of behavior | 3.44e-07 | 128 | 107 | 8 | GO:0050795 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 4.45e-07 | 56 | 107 | 6 | GO:0002418 | |
| GeneOntologyBiologicalProcess | receptor internalization | 4.54e-07 | 182 | 107 | 9 | GO:0031623 | |
| GeneOntologyBiologicalProcess | regulation of ERBB signaling pathway | 5.45e-07 | 93 | 107 | 7 | GO:1901184 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 6.10e-07 | 59 | 107 | 6 | GO:0045671 | |
| GeneOntologyBiologicalProcess | platelet aggregation | 6.30e-07 | 95 | 107 | 7 | GO:0070527 | |
| GeneOntologyBiologicalProcess | epidermal growth factor receptor signaling pathway | 6.46e-07 | 139 | 107 | 8 | GO:0007173 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 6.75e-07 | 60 | 107 | 6 | GO:0030851 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 6.75e-07 | 60 | 107 | 6 | GO:0045922 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 6.77e-07 | 96 | 107 | 7 | GO:0002704 | |
| GeneOntologyBiologicalProcess | cellular response to peptide hormone stimulus | PSG1 PSG2 PSG3 PSG6 PSG11 TYK2 LPIN3 UMODL1 LPIN2 PSG8 SLC30A10 SORL1 | 6.80e-07 | 381 | 107 | 12 | GO:0071375 |
| GeneOntologyBiologicalProcess | fatty acid biosynthetic process | 6.81e-07 | 191 | 107 | 9 | GO:0006633 | |
| GeneOntologyBiologicalProcess | fatty acid metabolic process | PSG1 PSG2 PSG3 PSG6 PSG11 ELOVL1 ACSS2 HNF4A LPIN3 PLA2G4B LPIN2 PEDS1 PSG8 | 7.88e-07 | 461 | 107 | 13 | GO:0006631 |
| GeneOntologyBiologicalProcess | monocarboxylic acid biosynthetic process | 1.02e-06 | 260 | 107 | 10 | GO:0072330 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 1.19e-06 | 66 | 107 | 6 | GO:0010543 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 1.31e-06 | 67 | 107 | 6 | GO:0045601 | |
| GeneOntologyBiologicalProcess | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 1.32e-06 | 334 | 107 | 11 | GO:0051896 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | 1.41e-06 | 107 | 107 | 7 | GO:0042130 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | HIP1 PSG1 PSG2 PSG3 PSG6 PSG11 ITGA5 NRP1 NEDD4 TYK2 ADAMTS12 VPS13A KDR PSG8 SLC30A10 SORL1 | 1.50e-06 | 747 | 107 | 16 | GO:0007169 |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 1.56e-06 | 69 | 107 | 6 | GO:0030195 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 1.69e-06 | 70 | 107 | 6 | GO:0045124 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 1.69e-06 | 70 | 107 | 6 | GO:1900047 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 1.84e-06 | 71 | 107 | 6 | GO:0043114 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 1.84e-06 | 71 | 107 | 6 | GO:0002347 | |
| GeneOntologyBiologicalProcess | ERBB signaling pathway | 1.87e-06 | 160 | 107 | 8 | GO:0038127 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 2.00e-06 | 72 | 107 | 6 | GO:0050819 | |
| GeneOntologyBiologicalProcess | feeding behavior | 2.05e-06 | 162 | 107 | 8 | GO:0007631 | |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 2.16e-06 | 114 | 107 | 7 | GO:0045824 | |
| GeneOntologyBiologicalProcess | sprouting angiogenesis | 2.20e-06 | 220 | 107 | 9 | GO:0002040 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 2.76e-06 | 76 | 107 | 6 | GO:0042269 | |
| GeneOntologyBiologicalProcess | multi-multicellular organism process | 3.09e-06 | 294 | 107 | 10 | GO:0044706 | |
| GeneOntologyBiologicalProcess | response to peptide hormone | PSG1 PSG2 PSG3 PSG6 PSG11 GATM TYK2 LPIN3 UMODL1 LPIN2 PSG8 SLC30A10 SORL1 | 3.68e-06 | 530 | 107 | 13 | GO:0043434 |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 3.72e-06 | 80 | 107 | 6 | GO:0002715 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 3.72e-06 | 80 | 107 | 6 | GO:0046850 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte proliferation | 3.79e-06 | 124 | 107 | 7 | GO:0050672 | |
| GeneOntologyBiologicalProcess | homotypic cell-cell adhesion | 3.79e-06 | 124 | 107 | 7 | GO:0034109 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 1.20e-10 | 16 | 107 | 6 | GO:0070021 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 6.86e-06 | 90 | 107 | 6 | GO:0016328 | |
| GeneOntologyCellularComponent | ciliary membrane | 1.12e-05 | 98 | 107 | 6 | GO:0060170 | |
| GeneOntologyCellularComponent | T cell receptor complex | 2.09e-05 | 163 | 107 | 7 | GO:0042101 | |
| GeneOntologyCellularComponent | anchoring junction | PSG1 PSG2 PSG3 PSG6 PSG11 ADGRB1 DBN1 ITGA5 NRP1 PTPN6 SLC8A3 ANO7 KDR PSG8 MARVELD2 KDF1 | 3.60e-05 | 976 | 107 | 16 | GO:0070161 |
| GeneOntologyCellularComponent | basolateral plasma membrane | 3.97e-05 | 320 | 107 | 9 | GO:0016323 | |
| GeneOntologyCellularComponent | receptor complex | PSG1 PSG2 PSG3 PSG6 PSG11 ITGA5 NRP1 TYK2 PTPN6 KDR PSG8 GPRC5B | 4.26e-05 | 581 | 107 | 12 | GO:0043235 |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 7.92e-05 | 350 | 107 | 9 | GO:0098802 | |
| GeneOntologyCellularComponent | basal plasma membrane | 8.64e-05 | 354 | 107 | 9 | GO:0009925 | |
| GeneOntologyCellularComponent | transferase complex | PRAMEF33 PRAMEF10 PHF20 PSG1 PSG2 PSG3 PSG6 PRAMEF19 PSG11 RNF8 NEDD4 MKLN1 UBR3 PSG8 TAF1L | 1.14e-04 | 963 | 107 | 15 | GO:1990234 |
| GeneOntologyCellularComponent | basal part of cell | 1.42e-04 | 378 | 107 | 9 | GO:0045178 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 1.58e-04 | 157 | 107 | 6 | GO:1902554 | |
| GeneOntologyCellularComponent | cilium | IFT27 CATSPERE PRAMEF10 PSG1 PSG2 PSG3 PSG6 PRAMEF19 PSG11 MKS1 PPP3CC VPS13A PSG8 USP48 | 1.95e-04 | 898 | 107 | 14 | GO:0005929 |
| GeneOntologyCellularComponent | cell-cell junction | PSG1 PSG2 PSG3 PSG6 PSG11 ADGRB1 DBN1 ITGA5 PTPN6 PSG8 MARVELD2 | 2.24e-04 | 591 | 107 | 11 | GO:0005911 |
| GeneOntologyCellularComponent | postsynaptic membrane | 2.37e-04 | 405 | 107 | 9 | GO:0045211 | |
| GeneOntologyCellularComponent | protein kinase complex | 2.43e-04 | 170 | 107 | 6 | GO:1902911 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 3.33e-04 | 519 | 107 | 10 | GO:0009897 | |
| GeneOntologyCellularComponent | cell projection membrane | 3.74e-04 | 431 | 107 | 9 | GO:0031253 | |
| GeneOntologyCellularComponent | sorting endosome | 3.84e-04 | 6 | 107 | 2 | GO:0097443 | |
| GeneOntologyCellularComponent | cell surface | PSG1 PSG2 PSG3 PSG6 PSG7 PSG11 SLC46A1 ITGA5 IZUMO1R NRP1 UMODL1 KDR PSG8 GPRC5B SORL1 | 5.30e-04 | 1111 | 107 | 15 | GO:0009986 |
| GeneOntologyCellularComponent | adherens junction | 7.83e-04 | 212 | 107 | 6 | GO:0005912 | |
| GeneOntologyCellularComponent | apical plasma membrane | 8.95e-04 | 487 | 107 | 9 | GO:0016324 | |
| GeneOntologyCellularComponent | apical part of cell | PAPPA2 PSG1 MYO5B PSG2 PSG3 PSG6 PSG11 SLC46A1 PSG8 MARVELD2 | 9.22e-04 | 592 | 107 | 10 | GO:0045177 |
| GeneOntologyCellularComponent | recycling endosome | 9.94e-04 | 222 | 107 | 6 | GO:0055037 | |
| GeneOntologyCellularComponent | endosome membrane | MYO5B SLC46A1 PLEKHM2 FIG4 PLA2G4B VPS13A MKLN1 SLC30A10 VPS13B SORL1 | 1.05e-03 | 602 | 107 | 10 | GO:0010008 |
| GeneOntologyCellularComponent | postsynaptic endosome membrane | 1.39e-03 | 11 | 107 | 2 | GO:0098895 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 1.69e-03 | 335 | 107 | 7 | GO:0061695 | |
| GeneOntologyCellularComponent | side of membrane | PSG1 PSG2 PSG3 PSG6 PSG11 ITGA5 IZUMO1R TYK2 UMODL1 KDR PSG8 ALG1 | 1.73e-03 | 875 | 107 | 12 | GO:0098552 |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 1.79e-03 | 47 | 107 | 3 | GO:0031462 | |
| GeneOntologyCellularComponent | ubiquitin ligase complex | 2.24e-03 | 352 | 107 | 7 | GO:0000151 | |
| GeneOntologyCellularComponent | nuclear envelope lumen | 2.27e-03 | 14 | 107 | 2 | GO:0005641 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | CATSPERE PSG1 PSG2 PSG3 PSG6 PSG11 ITGA5 TYK2 PTPN6 CACNA2D4 PSG8 | 2.29e-03 | 785 | 107 | 11 | GO:0098797 |
| GeneOntologyCellularComponent | cell cortex | 3.00e-03 | 371 | 107 | 7 | GO:0005938 | |
| GeneOntologyCellularComponent | synaptic membrane | 3.05e-03 | 583 | 107 | 9 | GO:0097060 | |
| GeneOntologyCellularComponent | postsynaptic actin cytoskeleton | 4.19e-03 | 19 | 107 | 2 | GO:0098871 | |
| GeneOntologyCellularComponent | sperm midpiece | 4.33e-03 | 64 | 107 | 3 | GO:0097225 | |
| GeneOntologyCellularComponent | early endosome membrane | 4.71e-03 | 212 | 107 | 5 | GO:0031901 | |
| GeneOntologyCellularComponent | cytosolic region | 5.57e-03 | 70 | 107 | 3 | GO:0099522 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 9.17e-10 | 17 | 94 | 6 | MP:0031047 | |
| MousePheno | decreased carbon dioxide production | 1.14e-09 | 31 | 94 | 7 | MP:0008964 | |
| MousePheno | increased skeletal muscle triglyceride level | 3.94e-09 | 21 | 94 | 6 | MP:0031415 | |
| MousePheno | decreased fatty acid oxidation | 9.60e-09 | 24 | 94 | 6 | MP:0014172 | |
| MousePheno | increased abdominal fat pad weight | 2.08e-08 | 27 | 94 | 6 | MP:0009286 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 2.63e-08 | 28 | 94 | 6 | MP:0020950 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 5.06e-08 | 31 | 94 | 6 | MP:0031413 | |
| MousePheno | decreased susceptibility to infection induced morbidity/mortality | 1.08e-07 | 120 | 94 | 9 | MP:0009786 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 1.09e-07 | 35 | 94 | 6 | MP:0031618 | |
| MousePheno | abnormal muscle triglyceride level | 1.30e-07 | 36 | 94 | 6 | MP:0031412 | |
| MousePheno | decreased muscle cell glucose uptake | 2.15e-07 | 39 | 94 | 6 | MP:0030022 | |
| MousePheno | abnormal muscle cell glucose uptake | 3.10e-07 | 67 | 94 | 7 | MP:0004130 | |
| MousePheno | abnormal carbon dioxide production | 3.10e-07 | 67 | 94 | 7 | MP:0008962 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 4.52e-07 | 44 | 94 | 6 | MP:0031023 | |
| MousePheno | abnormal vascular wound healing | 5.63e-07 | 73 | 94 | 7 | MP:0004883 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 6.77e-07 | 47 | 94 | 6 | MP:0031617 | |
| MousePheno | decreased respiratory quotient | 7.22e-07 | 110 | 94 | 8 | MP:0010379 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 8.72e-07 | 49 | 94 | 6 | MP:0020948 | |
| MousePheno | polyphagia | 1.06e-06 | 80 | 94 | 7 | MP:0001433 | |
| MousePheno | decreased energy expenditure | 1.32e-06 | 119 | 94 | 8 | MP:0004890 | |
| MousePheno | decreased cellular glucose uptake | 1.40e-06 | 53 | 94 | 6 | MP:0003926 | |
| MousePheno | abnormal fatty acid oxidation | 1.57e-06 | 54 | 94 | 6 | MP:0010953 | |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 2.94e-06 | 60 | 94 | 6 | MP:0009790 | |
| MousePheno | abnormal lipid oxidation | 3.24e-06 | 61 | 94 | 6 | MP:0010951 | |
| MousePheno | increased insulin secretion | 4.31e-06 | 64 | 94 | 6 | MP:0003058 | |
| MousePheno | abnormal cellular glucose uptake | 5.45e-06 | 102 | 94 | 7 | MP:0003925 | |
| MousePheno | obese | 1.07e-05 | 113 | 94 | 7 | MP:0001261 | |
| MousePheno | decreased oxygen consumption | 1.47e-05 | 79 | 94 | 6 | MP:0005290 | |
| MousePheno | decreased circulating triglyceride level | 1.56e-05 | 275 | 94 | 10 | MP:0002644 | |
| MousePheno | abnormal large intestine morphology | 1.61e-05 | 276 | 94 | 10 | MP:0000489 | |
| MousePheno | abnormal susceptibility to infection induced morbidity/mortality | 1.76e-05 | 279 | 94 | 10 | MP:0009785 | |
| MousePheno | decreased susceptibility to Riboviria infection | 1.83e-05 | 82 | 94 | 6 | MP:0020914 | |
| MousePheno | increased circulating leptin level | 2.08e-05 | 125 | 94 | 7 | MP:0005669 | |
| MousePheno | decreased triglyceride level | PSG1 PSG2 PSG3 PSG6 PSG11 GATM HNF4A LPIN3 SH3TC1 LPIN2 PSG8 | 2.12e-05 | 348 | 94 | 11 | MP:0005318 |
| MousePheno | increased physiological sensitivity to xenobiotic | 2.18e-05 | 286 | 94 | 10 | MP:0008873 | |
| MousePheno | abnormal respiratory quotient | 2.59e-05 | 178 | 94 | 8 | MP:0004129 | |
| MousePheno | abnormal energy expenditure | 4.70e-05 | 313 | 94 | 10 | MP:0005450 | |
| MousePheno | abnormal glycogen homeostasis | 5.16e-05 | 144 | 94 | 7 | MP:0005438 | |
| MousePheno | decreased susceptibility to infection | 5.35e-05 | 255 | 94 | 9 | MP:0002409 | |
| MousePheno | abnormal energy homeostasis | 5.97e-05 | 322 | 94 | 10 | MP:0005448 | |
| MousePheno | abnormal colon morphology | 7.26e-05 | 152 | 94 | 7 | MP:0000495 | |
| MousePheno | increased body size | PSG1 PSG2 PSG3 PSG6 PSG11 HNF4G TYK2 PSG8 MARVELD2 CSMD1 KDM4B | 9.17e-05 | 409 | 94 | 11 | MP:0001264 |
| MousePheno | decreased lipid level | PSG1 PSG2 PSG3 PSG6 PSG11 GATM DBN1 HNF4A TYK2 LPIN3 SH3TC1 LPIN2 PEDS1 PSG8 FTO | 9.54e-05 | 727 | 94 | 15 | MP:0014461 |
| MousePheno | abnormal induced morbidity/mortality | HGFAC PSG1 PSG2 HECTD3 PSG3 PSG6 PSG11 RNF8 GATM BCHE TYK2 PTPN6 PLEKHM2 PSG8 MTO1 | 1.11e-04 | 737 | 94 | 15 | MP:0001657 |
| MousePheno | increased total tissue mass | 1.64e-04 | 364 | 94 | 10 | MP:0012323 | |
| MousePheno | increased body weight | 1.64e-04 | 364 | 94 | 10 | MP:0001260 | |
| MousePheno | abnormal circulating leptin level | 1.87e-04 | 236 | 94 | 8 | MP:0005667 | |
| MousePheno | decreased susceptibility to viral infection | 1.94e-04 | 125 | 94 | 6 | MP:0002410 | |
| MousePheno | abnormal susceptibility to Riboviria infection | 2.55e-04 | 186 | 94 | 7 | MP:0020912 | |
| MousePheno | increased food intake | 2.81e-04 | 189 | 94 | 7 | MP:0011939 | |
| MousePheno | abnormal wound healing | 3.19e-04 | 193 | 94 | 7 | MP:0005023 | |
| MousePheno | abnormal oxygen consumption | 3.39e-04 | 195 | 94 | 7 | MP:0005288 | |
| MousePheno | increased incidence of tumors by chemical induction | 3.72e-04 | 141 | 94 | 6 | MP:0004499 | |
| MousePheno | abnormal abdominal fat pad morphology | 3.79e-04 | 262 | 94 | 8 | MP:0000010 | |
| MousePheno | increased total body fat amount | 5.52e-04 | 424 | 94 | 10 | MP:0010024 | |
| MousePheno | increased lean body mass | 6.20e-04 | 354 | 94 | 9 | MP:0003960 | |
| MousePheno | increased circulating insulin level | 6.31e-04 | 283 | 94 | 8 | MP:0002079 | |
| MousePheno | abnormal cranial neural crest cell morphology | 6.59e-04 | 6 | 94 | 2 | MP:0012754 | |
| MousePheno | abnormal circulating triglyceride level | 6.74e-04 | 516 | 94 | 11 | MP:0011969 | |
| MousePheno | abnormal insulin secretion | 1.03e-03 | 171 | 94 | 6 | MP:0003564 | |
| MousePheno | abnormal intestine morphology | PRAMEF10 PSG1 MYO5B PSG2 PSG3 PSG6 PRAMEF19 PSG11 GATM PSG8 CPNE7 | 1.07e-03 | 546 | 94 | 11 | MP:0000477 |
| MousePheno | increased incidence of induced tumors | 1.09e-03 | 173 | 94 | 6 | MP:0002021 | |
| MousePheno | small mandible | 1.10e-03 | 116 | 94 | 5 | MP:0004592 | |
| MousePheno | abnormal triglyceride level | PSG1 PSG2 PSG3 PSG6 PSG11 GATM HNF4A LPIN3 SH3TC1 LPIN2 PSG8 FTO | 1.16e-03 | 639 | 94 | 12 | MP:0000187 |
| MousePheno | abnormal endocrine pancreas secretion | 1.19e-03 | 176 | 94 | 6 | MP:0014195 | |
| MousePheno | abnormal fat pad morphology | 1.24e-03 | 314 | 94 | 8 | MP:0005334 | |
| MousePheno | abnormal digestive system morphology | IFT27 PRAMEF10 PSG1 MYO5B PSG2 HECTD3 PSG3 PSG6 PRAMEF19 PSG11 GATM MKS1 NEDD4 PSG8 MARVELD2 KDF1 SMAD2 CPNE7 | 1.29e-03 | 1233 | 94 | 18 | MP:0000462 |
| MousePheno | impaired glucose tolerance | 1.42e-03 | 480 | 94 | 10 | MP:0005293 | |
| MousePheno | abnormal pancreas secretion | 1.46e-03 | 183 | 94 | 6 | MP:0002694 | |
| Domain | Ig_2 | 1.74e-07 | 73 | 105 | 7 | PF13895 | |
| Domain | V-set | 9.41e-06 | 184 | 105 | 8 | PF07686 | |
| Domain | ig | 1.19e-05 | 190 | 105 | 8 | PF00047 | |
| Domain | Immunoglobulin | 1.19e-05 | 190 | 105 | 8 | IPR013151 | |
| Domain | Ig_V-set | 1.66e-05 | 199 | 105 | 8 | IPR013106 | |
| Domain | IGc2 | 5.45e-05 | 235 | 105 | 8 | SM00408 | |
| Domain | Ig_sub2 | 5.45e-05 | 235 | 105 | 8 | IPR003598 | |
| Domain | - | PAPPA2 FNDC3B PSG1 PSG2 PSG3 PSG6 PSG7 PSG11 TGM5 UMODL1 KDR PSG8 SORL1 | 8.78e-05 | 663 | 105 | 13 | 2.60.40.10 |
| Domain | Lipin_N | 9.36e-05 | 3 | 105 | 2 | IPR007651 | |
| Domain | Lipin_mid | 9.36e-05 | 3 | 105 | 2 | IPR031703 | |
| Domain | Lipin_N | 9.36e-05 | 3 | 105 | 2 | PF04571 | |
| Domain | Lipin_mid | 9.36e-05 | 3 | 105 | 2 | PF16876 | |
| Domain | Ig-like_fold | PAPPA2 FNDC3B PSG1 PSG2 PSG3 PSG6 PSG7 PSG11 TGM5 UMODL1 KDR PSG8 SORL1 | 1.64e-04 | 706 | 105 | 13 | IPR013783 |
| Domain | SHR-BD | 1.86e-04 | 4 | 105 | 2 | IPR009543 | |
| Domain | VPS13_C | 1.86e-04 | 4 | 105 | 2 | PF16909 | |
| Domain | VPS13_C | 1.86e-04 | 4 | 105 | 2 | IPR031645 | |
| Domain | SHR-BD | 1.86e-04 | 4 | 105 | 2 | PF06650 | |
| Domain | COUP_TF | 3.10e-04 | 5 | 105 | 2 | IPR003068 | |
| Domain | Autophagy-rel_C | 3.10e-04 | 5 | 105 | 2 | IPR015412 | |
| Domain | ATG_C | 3.10e-04 | 5 | 105 | 2 | PF09333 | |
| Domain | LNS2 | 4.63e-04 | 6 | 105 | 2 | IPR013209 | |
| Domain | LNS2 | 4.63e-04 | 6 | 105 | 2 | SM00775 | |
| Domain | LNS2 | 4.63e-04 | 6 | 105 | 2 | PF08235 | |
| Domain | LNS2/PITP | 4.63e-04 | 6 | 105 | 2 | IPR031315 | |
| Domain | Chorein_N | 8.57e-04 | 8 | 105 | 2 | PF12624 | |
| Domain | VPS13_N | 8.57e-04 | 8 | 105 | 2 | IPR026854 | |
| Domain | Retinoid-X_rcpt/HNF4 | 1.37e-03 | 10 | 105 | 2 | IPR000003 | |
| Domain | IG | 2.59e-03 | 421 | 105 | 8 | SM00409 | |
| Domain | Ig_sub | 2.59e-03 | 421 | 105 | 8 | IPR003599 | |
| Domain | CUB | 2.64e-03 | 49 | 105 | 3 | PF00431 | |
| Domain | ZP_2 | 2.73e-03 | 14 | 105 | 2 | PS51034 | |
| Domain | ZP_1 | 2.73e-03 | 14 | 105 | 2 | PS00682 | |
| Domain | CUB | 2.79e-03 | 50 | 105 | 3 | SM00042 | |
| Domain | - | 3.12e-03 | 52 | 105 | 3 | 2.60.120.290 | |
| Domain | ZP | 3.13e-03 | 15 | 105 | 2 | SM00241 | |
| Domain | CUB | 3.30e-03 | 53 | 105 | 3 | PS01180 | |
| Domain | ZP_dom | 4.03e-03 | 17 | 105 | 2 | IPR001507 | |
| Domain | Zona_pellucida | 4.03e-03 | 17 | 105 | 2 | PF00100 | |
| Domain | CUB_dom | 4.05e-03 | 57 | 105 | 3 | IPR000859 | |
| Domain | PRAME_family | 5.03e-03 | 19 | 105 | 2 | IPR026271 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 8.14e-07 | 188 | 77 | 9 | MM15828 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 1.06e-06 | 194 | 77 | 9 | M16312 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | 1.09e-06 | 99 | 77 | 7 | MM14624 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 2.28e-06 | 158 | 77 | 8 | MM14812 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 7.99e-05 | 258 | 77 | 8 | MM14572 | |
| Pathway | WP_ETHER_LIPID_BIOSYNTHESIS | 1.67e-04 | 20 | 77 | 3 | M46451 | |
| Pathway | WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1 | 2.91e-04 | 5 | 77 | 2 | M42561 | |
| Pubmed | 7.20e-15 | 14 | 107 | 7 | 9047385 | ||
| Pubmed | 1.35e-14 | 15 | 107 | 7 | 21029969 | ||
| Pubmed | CEACAM1 on activated NK cells inhibits NKG2D-mediated cytolytic function and signaling. | 2.39e-14 | 16 | 107 | 7 | 23696226 | |
| Pubmed | 2.39e-14 | 16 | 107 | 7 | 9867848 | ||
| Pubmed | 1.04e-13 | 19 | 107 | 7 | 22496641 | ||
| Pubmed | 7.08e-13 | 24 | 107 | 7 | 34233187 | ||
| Pubmed | In vivo validation of late-onset Alzheimer's disease genetic risk factors. | 9.82e-13 | 25 | 107 | 7 | 38687251 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 1.24e-12 | 13 | 107 | 6 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 1.24e-12 | 13 | 107 | 6 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 1.24e-12 | 13 | 107 | 6 | 16638824 | |
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 20044046 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 32150576 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 6265583 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 1.24e-12 | 13 | 107 | 6 | 12832451 | |
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 25406283 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 1.24e-12 | 13 | 107 | 6 | 21670291 | |
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 22162753 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 2702644 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 8380065 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 1279194 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 25724769 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 1.24e-12 | 13 | 107 | 6 | 22092845 | |
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 11801635 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 1.24e-12 | 13 | 107 | 6 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 1.24e-12 | 13 | 107 | 6 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 1.24e-12 | 13 | 107 | 6 | 23800882 | |
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 19285068 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 21760897 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 1.24e-12 | 13 | 107 | 6 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 1.24e-12 | 13 | 107 | 6 | 39168268 | |
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 8402684 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 16619040 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 1.24e-12 | 13 | 107 | 6 | 8209741 | |
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 1.24e-12 | 13 | 107 | 6 | 21949477 | |
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 26219866 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 2133556 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 32521208 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 19406938 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 1.24e-12 | 13 | 107 | 6 | 29967450 | |
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 1.24e-12 | 13 | 107 | 6 | 19358828 | |
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 16680193 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 1653760 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 1.24e-12 | 13 | 107 | 6 | 34058224 | |
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 10964771 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 32169849 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 1.24e-12 | 13 | 107 | 6 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 1.24e-12 | 13 | 107 | 6 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 1.24e-12 | 13 | 107 | 6 | 15316023 | |
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 1.24e-12 | 13 | 107 | 6 | 23935487 | |
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 15331748 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 1.24e-12 | 13 | 107 | 6 | 22406619 | |
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 7628460 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 1.24e-12 | 13 | 107 | 6 | 25972571 | |
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 19008452 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 1.24e-12 | 13 | 107 | 6 | 15220458 | |
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 18843289 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 15207636 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 21081647 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 11133662 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 11483763 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 2164599 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 29396368 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 18003729 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 1.24e-12 | 13 | 107 | 6 | 33352461 | |
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 38381498 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 20739537 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 1633107 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 1.24e-12 | 13 | 107 | 6 | 27695943 | |
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 20404914 | ||
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 1.24e-12 | 13 | 107 | 6 | 32027621 | |
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 1.24e-12 | 13 | 107 | 6 | 27777319 | |
| Pubmed | 1.24e-12 | 13 | 107 | 6 | 18848945 | ||
| Pubmed | 2.17e-12 | 14 | 107 | 6 | 37531413 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 2.17e-12 | 14 | 107 | 6 | 34666041 | |
| Pubmed | 2.17e-12 | 14 | 107 | 6 | 34619794 | ||
| Pubmed | SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. | 2.17e-12 | 14 | 107 | 6 | 17081782 | |
| Pubmed | Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice. | 2.17e-12 | 14 | 107 | 6 | 32209360 | |
| Pubmed | 2.17e-12 | 14 | 107 | 6 | 11994468 | ||
| Pubmed | 2.17e-12 | 14 | 107 | 6 | 11850617 | ||
| Pubmed | 2.17e-12 | 14 | 107 | 6 | 20381490 | ||
| Pubmed | CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. | 2.17e-12 | 14 | 107 | 6 | 26196244 | |
| Pubmed | 2.17e-12 | 14 | 107 | 6 | 8896983 | ||
| Pubmed | 2.17e-12 | 14 | 107 | 6 | 22962327 | ||
| Pubmed | 2.17e-12 | 14 | 107 | 6 | 17623671 | ||
| Pubmed | 2.17e-12 | 14 | 107 | 6 | 26846848 | ||
| Pubmed | CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. | 2.17e-12 | 14 | 107 | 6 | 18794798 | |
| Pubmed | 2.17e-12 | 14 | 107 | 6 | 23469261 | ||
| Interaction | PSG4 interactions | 4.43e-08 | 8 | 103 | 4 | int:PSG4 | |
| Interaction | PSG1 interactions | 6.16e-06 | 51 | 103 | 5 | int:PSG1 | |
| Cytoband | 19q13.2 | 2.68e-06 | 164 | 108 | 6 | 19q13.2 | |
| Cytoband | 1p36.21 | 1.55e-05 | 63 | 108 | 4 | 1p36.21 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 2.81e-15 | 11 | 69 | 7 | 1315 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 2.87e-06 | 163 | 69 | 7 | 590 | |
| GeneFamily | Lipins | 4.30e-05 | 3 | 69 | 2 | 1043 | |
| GeneFamily | Bardet-Biedl syndrome associated|BBSome | 2.88e-03 | 21 | 69 | 2 | 980 | |
| GeneFamily | PRAME family | 3.75e-03 | 24 | 69 | 2 | 686 | |
| GeneFamily | NLR family | 4.07e-03 | 25 | 69 | 2 | 666 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 4.79e-11 | 32 | 107 | 7 | MM2 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 4.56e-09 | 135 | 107 | 9 | MM965 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 5.92e-09 | 35 | 107 | 6 | MM757 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 2.45e-08 | 75 | 107 | 7 | MM605 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 4.29e-08 | 48 | 107 | 6 | MM531 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS | 1.10e-07 | 93 | 107 | 7 | M40279 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | 9.76e-07 | 128 | 107 | 7 | MM1000 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 1.55e-06 | 87 | 107 | 6 | MM851 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | 1.77e-06 | 201 | 107 | 8 | MM1294 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_UP | 2.05e-06 | 143 | 107 | 7 | MM989 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_CSH1_CSH2_POSITIVE_CELLS | 3.96e-06 | 224 | 107 | 8 | M40145 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 1.01e-05 | 182 | 107 | 7 | MM993 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_MYELOID_CELL_AGEING | 3.32e-05 | 219 | 107 | 7 | MM3826 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_DN | 4.94e-05 | 159 | 107 | 6 | MM760 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_DN | 7.64e-05 | 436 | 107 | 9 | MM1326 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED | 8.78e-05 | 57 | 107 | 4 | MM1262 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | 1.00e-04 | 261 | 107 | 7 | MM1277 | |
| Coexpression | GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_UP | 1.75e-04 | 200 | 107 | 6 | M7745 | |
| Coexpression | GSE24210_TCONV_VS_TREG_UP | 1.75e-04 | 200 | 107 | 6 | M7851 | |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_UP | 1.79e-04 | 201 | 107 | 6 | MM1006 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-6|TCGA-Cervix / Sample_Type by Project: Shred V9 | 4.27e-08 | 136 | 108 | 7 | 2c723777fadc5946df67d3e992471d8134b827f4 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l48|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.97e-07 | 170 | 108 | 7 | 070d8683d1a5cc7d594ff0453c961a9bf982c2d0 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.46e-06 | 168 | 108 | 6 | c7021748003e5949f7caf7b3291c5bad294948c1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.48e-06 | 182 | 108 | 6 | e1e58176f533092b6b974ca1ce8b02192a6e193d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.48e-06 | 182 | 108 | 6 | 57bb5a2da976464ba7c4460106bd9f692008ebd9 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.02e-06 | 185 | 108 | 6 | 554c5d812197fbf66bf279fcc953277e926ade15 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.40e-06 | 187 | 108 | 6 | 8bd635abdee5d5a12a3f7bf74eab4282e8e40741 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.40e-06 | 187 | 108 | 6 | 3cb8cd7f7a4306ff74d1f7f9964014008ec1c6a0 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.45e-06 | 192 | 108 | 6 | 3e1a4cb0d83efd502c8613d41a1692bdda5860ed | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.38e-06 | 196 | 108 | 6 | b15812354128c12a588d79ef449d787e74835f3b | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-05 | 172 | 108 | 5 | f814b6134ad608015765399d54cc1e5e1873ed34 | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-05 | 172 | 108 | 5 | a6fb1bde8d942c7b5caaf7bd14de0b7ce32fda55 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.60e-05 | 174 | 108 | 5 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.96e-05 | 176 | 108 | 5 | 3494ffa8555e6edf4b1250e10434bae9b73ec845 | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.96e-05 | 176 | 108 | 5 | d43f6b7828b98e1dab7b726a5f99499d65a7db80 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.15e-05 | 177 | 108 | 5 | 2f81b26be89cc2fd8eafadaf7eae3c6ad6521462 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.15e-05 | 177 | 108 | 5 | c1f838e425ebb04482829b1957e3c1347127e6de | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.54e-05 | 179 | 108 | 5 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.74e-05 | 180 | 108 | 5 | 7368ab31c3273374ef260f0d710d4eea83cbc4a2 | |
| ToppCell | COPD-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 8.16e-05 | 182 | 108 | 5 | 19db653fe04c5e2957eea1f4893b1c1fca4ddcbd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.16e-05 | 182 | 108 | 5 | 4a9c13932e7163fd37a3dcc4c6ca3bbea5372459 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.16e-05 | 182 | 108 | 5 | f00eec1f434d92d44787d3d3343476c98c3de5b4 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.16e-05 | 182 | 108 | 5 | a512863304fad80acaab60a8c6107eb7c9cbac99 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 8.37e-05 | 183 | 108 | 5 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 8.59e-05 | 184 | 108 | 5 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.81e-05 | 185 | 108 | 5 | 5527fa9d2e0b2f3607602e18ba94de4e9bbc6824 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Papillary_Renal_Cell_Carcinoma|TCGA-Kidney / Sample_Type by Project: Shred V9 | 8.81e-05 | 185 | 108 | 5 | 46f4f6f20b1e152922f6f2ba1244c56e48a49b79 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-05 | 186 | 108 | 5 | b58db5abdd3e9f0214b198c3cbd09b0b3c321eab | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-05 | 186 | 108 | 5 | cd6502bbf9dce318fdbb4965d49df8951e5f795c | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.27e-05 | 187 | 108 | 5 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | 11.5-Airway-Mesenchymal-Pericyte|Airway / Age, Tissue, Lineage and Cell class | 9.50e-05 | 188 | 108 | 5 | 916971d8660fd20f616346953874e89d2cd13e88 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.50e-05 | 188 | 108 | 5 | 789d1be574e693d7bdd488f3c72c6df788e47b47 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.74e-05 | 189 | 108 | 5 | db09d591b885ce2bc9e353f08b6694e2192582e1 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.74e-05 | 189 | 108 | 5 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.99e-05 | 190 | 108 | 5 | 10125091ad648163777b02e9f0d5e8d7f17d44a5 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-04 | 191 | 108 | 5 | b5328733da3d3d77c4f6fc5e2ba2035f8898f172 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 192 | 108 | 5 | 2bfac6b3956265205ca47d06888851ed68b65999 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.05e-04 | 192 | 108 | 5 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 192 | 108 | 5 | d525f7f088a53110912600a7c9f6d33b9270d534 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-04 | 193 | 108 | 5 | dd443b83d328a9069ffe19ac3d74066e922515a5 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 194 | 108 | 5 | c8b9551b93a5aed62154b487db90130604a6125c | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-04 | 194 | 108 | 5 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 194 | 108 | 5 | ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-04 | 194 | 108 | 5 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-aorta_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 195 | 108 | 5 | 3969b8d5fcec8ef1831531a781f7bbcebab5a4ba | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-04 | 196 | 108 | 5 | c5fe470f11ee4962bcfb30cddfd8c078af5b1222 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 196 | 108 | 5 | 8f2031b1a9232c389517fbf3c29f47f9468b0077 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 196 | 108 | 5 | 48b4a9cea97a55190217deaf51bf867608c5a9a7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 196 | 108 | 5 | 473980c827443464d08a0be28c53e3536369b12a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.16e-04 | 196 | 108 | 5 | a44a648bf209ce037bfc7b3adfcb220aab60728c | |
| ToppCell | control-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.18e-04 | 197 | 108 | 5 | df2fe36cb96e2565a9d21c24cb4e451e8befd4be | |
| ToppCell | 3'-Child04-06-SmallIntestine-Endothelial-blood_vessel_EC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-04 | 198 | 108 | 5 | 99be7a7a84199dac598e993a5a0144d9030f13ce | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.24e-04 | 199 | 108 | 5 | b0a906586e58009f5ed9272fc29ba28e49c85ee6 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal-Intermediate|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.24e-04 | 199 | 108 | 5 | cf592d93612023a13de21e0fb8c6b13714f9af71 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-04 | 199 | 108 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 1.27e-04 | 200 | 108 | 5 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 1.27e-04 | 200 | 108 | 5 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.27e-04 | 200 | 108 | 5 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.27e-04 | 200 | 108 | 5 | abf4ba5fcb54cdeada0da1a8b956a30aa47679e4 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.27e-04 | 200 | 108 | 5 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.27e-04 | 200 | 108 | 5 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 1.27e-04 | 200 | 108 | 5 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.27e-04 | 200 | 108 | 5 | 851c57187db8bc91a393655bca5f13e787a723d4 | |
| Computational | Neighborhood of EGFR | 2.32e-08 | 32 | 62 | 6 | GNF2_EGFR | |
| Computational | Neighborhood of IGFBP1 | 4.10e-08 | 35 | 62 | 6 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 1.28e-07 | 42 | 62 | 6 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 2.25e-07 | 46 | 62 | 6 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 3.31e-07 | 49 | 62 | 6 | GNF2_KISS1 | |
| Computational | Neighborhood of CDKN1C | 3.97e-07 | 27 | 62 | 5 | GNF2_CDKN1C | |
| Drug | AC1L1IPV | 1.02e-09 | 43 | 105 | 7 | CID000004683 | |
| Drug | Rgd Peptide | 1.67e-06 | 239 | 105 | 9 | CID000104802 | |
| Disease | cD177 antigen measurement | 3.88e-09 | 18 | 103 | 5 | EFO_0021866 | |
| Disease | age at menarche | PAPPA2 FNDC3B HIP1 ATE1 IZUMO1R HNF4G GREB1 FTO CSMD1 KDM4B SMAD2 GPRC5B | 1.15e-06 | 594 | 103 | 12 | EFO_0004703 |
| Disease | maturity-onset diabetes of the young type 1 (implicated_via_orthology) | 1.21e-05 | 2 | 103 | 2 | DOID:0111099 (implicated_via_orthology) | |
| Disease | myoglobinuria (implicated_via_orthology) | 3.61e-05 | 3 | 103 | 2 | DOID:0080108 (implicated_via_orthology) | |
| Disease | Cohen syndrome (implicated_via_orthology) | 3.61e-05 | 3 | 103 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | apolipoprotein A 1 measurement | PAPPA2 HGFAC PSG1 MYO5B RNF8 SLC46A1 HNF4A NUP205 NRP1 LPIN2 SLC30A10 SORL1 | 4.10e-05 | 848 | 103 | 12 | EFO_0004614 |
| Disease | physical activity measurement, body mass index | 5.10e-05 | 114 | 103 | 5 | EFO_0004340, EFO_0008002 | |
| Disease | Fanconi syndrome (implicated_via_orthology) | 7.21e-05 | 4 | 103 | 2 | DOID:1062 (implicated_via_orthology) | |
| Disease | C-reactive protein measurement, high density lipoprotein cholesterol measurement | 2.28e-04 | 34 | 103 | 3 | EFO_0004458, EFO_0004612 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 3.33e-04 | 8 | 103 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | FEV/FEC ratio | KLHL6 FNDC3B BCHE ATE1 DENND2B C5orf34 FCGBP NETO1 KDR FTO CSMD1 SLC30A10 SORL1 | 3.49e-04 | 1228 | 103 | 13 | EFO_0004713 |
| Disease | Malignant neoplasm of breast | FNDC3B CATSPERE BCHE DBN1 NEDD4 C5orf34 SLC8A3 P3H2 KDR FTO VPS13B SORL1 | 3.70e-04 | 1074 | 103 | 12 | C0006142 |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 5.27e-04 | 45 | 103 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 5.27e-04 | 45 | 103 | 3 | EFO_0004623, EFO_0004792 | |
| Disease | maturity-onset diabetes of the young (implicated_via_orthology) | 5.33e-04 | 10 | 103 | 2 | DOID:0050524 (implicated_via_orthology) | |
| Disease | Dupuytren Contracture | 5.68e-04 | 108 | 103 | 4 | EFO_0004229 | |
| Disease | monokine induced by gamma interferon measurement | 8.06e-04 | 52 | 103 | 3 | EFO_0008236 | |
| Disease | Bardet-Biedl Syndrome | 9.18e-04 | 13 | 103 | 2 | C0752166 | |
| Disease | smoking behavior, body mass index | 9.25e-04 | 123 | 103 | 4 | EFO_0004318, EFO_0004340 | |
| Disease | coronary artery disease | FNDC3B HGFAC HECTD4 DENND2B NRP1 NEDD4 OIT3 FTO USP48 KDF1 KDM4B SMAD2 | 9.39e-04 | 1194 | 103 | 12 | EFO_0001645 |
| Disease | Antithrombotic agent use measurement | 9.50e-04 | 55 | 103 | 3 | EFO_0009925 | |
| Disease | Ischemic stroke, fibrinogen measurement | 9.50e-04 | 55 | 103 | 3 | EFO_0004623, HP_0002140 | |
| Disease | response to paliperidone, schizophrenia symptom severity measurement | 9.82e-04 | 216 | 103 | 5 | EFO_0007925, EFO_0007927 | |
| Disease | tuberculosis | 9.82e-04 | 216 | 103 | 5 | MONDO_0018076 | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 1.00e-03 | 56 | 103 | 3 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | fibrinogen measurement, factor VII measurement | 1.11e-03 | 58 | 103 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | pulse pressure measurement | PAPPA2 FNDC3B HGFAC HIP1 PSG1 HNF4G CWC22 PLEKHM2 ASB3 MKLN1 UBR3 FTO KDM4B | 1.12e-03 | 1392 | 103 | 13 | EFO_0005763 |
| Disease | visual perception measurement | 1.13e-03 | 223 | 103 | 5 | EFO_0009700 | |
| Disease | heart rate | 1.18e-03 | 225 | 103 | 5 | EFO_0004326 | |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 1.23e-03 | 15 | 103 | 2 | DOID:3146 (implicated_via_orthology) | |
| Disease | urolithiasis | 1.41e-03 | 63 | 103 | 3 | MONDO_0024647 | |
| Disease | obstructive sleep apnea | 1.61e-03 | 66 | 103 | 3 | EFO_0003918 | |
| Disease | venous thromboembolism, fibrinogen measurement | 1.68e-03 | 67 | 103 | 3 | EFO_0004286, EFO_0004623 | |
| Disease | inferior parietal cortex volume measurement | 1.99e-03 | 19 | 103 | 2 | EFO_0010307 | |
| Disease | free androgen index | 2.03e-03 | 374 | 103 | 6 | EFO_0007005 | |
| Disease | Amphetamine-Related Disorders | 2.32e-03 | 75 | 103 | 3 | C0236733 | |
| Disease | Amphetamine Abuse | 2.32e-03 | 75 | 103 | 3 | C0236807 | |
| Disease | Amphetamine Addiction | 2.32e-03 | 75 | 103 | 3 | C0236804 | |
| Disease | diastolic blood pressure, systolic blood pressure | 2.43e-03 | 670 | 103 | 8 | EFO_0006335, EFO_0006336 | |
| Disease | triacylglycerol 48:3 measurement | 2.66e-03 | 22 | 103 | 2 | EFO_0010406 | |
| Disease | sex interaction measurement, body mass index, age at assessment | 2.91e-03 | 23 | 103 | 2 | EFO_0004340, EFO_0008007, EFO_0008343 | |
| Disease | risky sexual behaviour measurement | 2.96e-03 | 169 | 103 | 4 | EFO_0007877 | |
| Disease | glioblastoma (is_implicated_in) | 3.17e-03 | 24 | 103 | 2 | DOID:3068 (is_implicated_in) | |
| Disease | serum alanine aminotransferase measurement | 3.41e-03 | 869 | 103 | 9 | EFO_0004735 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ELYVSVQWPCIPDLD | 246 | A0A0G2JMD5 | |
| NLEWEDCPPVSDYVV | 306 | Q5DID0 | |
| LSEDCLYLNVWIPAP | 116 | P06276 | |
| IQVCTPWLEAEDYPL | 341 | Q9BT22 | |
| VWAYDPESADPDELL | 121 | Q5SY80 | |
| GFPDEYPILKDCIWL | 2161 | Q96PZ7 | |
| CELDEEGIAYWEPPT | 616 | O14514 | |
| LARVPCPEIYDGDWL | 156 | Q8IU99 | |
| EPEWCDAEDPLFILY | 301 | Q9NR19 | |
| CFPDAKDWLPVSEYS | 746 | P78524 | |
| DPTPLTWSKCSEEYI | 426 | P58397 | |
| ASEAVDCKWYIRAPP | 196 | Q8TDF5 | |
| HLELALEYWCPTEPL | 456 | Q92621 | |
| PWEDDYELVPCEGLF | 691 | Q6IWH7 | |
| ECYLPSWLTPQYLDA | 381 | Q6IE37 | |
| CYWREPLPAVDLDTL | 836 | Q9BQK8 | |
| DILTLYELSTPLCWD | 286 | Q96NT5 | |
| LDPWYFVETVEADPL | 266 | Q8WZ60 | |
| IPYCSSDWALLREEE | 36 | Q96JY0 | |
| DLPPYESFEELWDKL | 1291 | P46934 | |
| DAELWPPRTLCELYS | 351 | Q7RTR2 | |
| EWRPQTYLELEGLPC | 1011 | Q4ZG55 | |
| PYSQELPCLCLEGWS | 171 | Q6ZVW7 | |
| PKDCPVSSYNEWDPL | 61 | P50440 | |
| VPSPEDKLYEECIPW | 36 | A6ND01 | |
| ELELGTEWCKPPYFS | 16 | Q6ZRQ5 | |
| TVWIKPEDQLPCYLT | 271 | Q9Y2Z2 | |
| EELEDTWLPYLTPKD | 21 | Q9C0B1 | |
| YPQLCLSESWKEVIP | 386 | Q6ZVZ8 | |
| YTDSLPWSVLECIKL | 556 | Q9HCG8 | |
| PPYWDNISDAAKDLV | 576 | Q9C098 | |
| WAKYIPAFCELPLDD | 201 | P41235 | |
| ALDPCSAYISLNEPW | 21 | Q8WWZ8 | |
| THSPEALEQLYPWEC | 156 | A5PLL7 | |
| EPDDWPYVVSITCLK | 891 | O94953 | |
| FYNKPPEIDITCWDA | 621 | Q16643 | |
| DLVTPSDCYVTLWLP | 26 | P0C869 | |
| LDPEANECWKEPPAY | 586 | Q8IVL5 | |
| EDCGNVELPPWSYSV | 1441 | Q9Y4D8 | |
| SPIPVSEYCESENKW | 321 | Q2M2Z5 | |
| PDNDERPWCYVVKDS | 341 | Q04756 | |
| PSYIPTDLLEWLCAL | 556 | Q8WXE0 | |
| VEWAKYIPAFCELPL | 151 | Q14541 | |
| LLPQYVSLCDLDAIW | 41 | Q9NZH0 | |
| SEKCEWLIQAPDPYQ | 51 | O14786 | |
| CAPLYSWRTEKEPLS | 156 | P08648 | |
| LTCLEDGLWSLPEVY | 1506 | Q9BXP8 | |
| ADPDLYCNEDSWQLP | 236 | Q9Y575 | |
| DKLWESPNVLCLVYD | 76 | Q9BW83 | |
| LYWSEDDQELIIPCL | 231 | O95273 | |
| VVTYDWDCQLALSLP | 586 | Q9Y6R7 | |
| PDSYCSILRPDEKWN | 451 | Q92562 | |
| LAGDWIYCITDIDPD | 681 | Q7Z3S7 | |
| DAYPDSPSACLVLNW | 876 | Q53EP0 | |
| YEDPKVACWLLDPDS | 1986 | O75417 | |
| EETRPLKCLVWDYDS | 296 | Q9UBL6 | |
| PECQYWGSELQLPTL | 111 | O75936 | |
| LGPAEDDLYSWILCP | 291 | A6NJJ6 | |
| DDLYSWILCPQPLGD | 296 | A6NJJ6 | |
| WRCDPVDYSNSPEAL | 91 | Q9BW60 | |
| DPEWDKPVSDIRYIS | 96 | Q8N4S9 | |
| DLLCPETYVWVPIEQ | 426 | O95260 | |
| ETYVWVPIEQCLPSL | 431 | O95260 | |
| ACPEEWKYPLSLALH | 246 | Q96MH7 | |
| DYSEECGRKEEWPVP | 271 | Q6NYC8 | |
| ILTCNPETPDASYLW | 166 | Q9UQ72 | |
| SLTCDPETPDASYLW | 166 | P11464 | |
| SLTCDPETPDASYLW | 166 | Q16557 | |
| VLESWLDYTGELEPP | 966 | Q9BVI0 | |
| PPWVIYLSCTSELDR | 946 | Q8IWE5 | |
| VWEPEPRACYTLEFK | 201 | O14926 | |
| LGVPCTENDYKLWSP | 621 | Q92673 | |
| GWEQLEVTCTPYLKE | 496 | Q9UKY4 | |
| EEDWETIYPCLSPKN | 126 | O76064 | |
| DDPDIVQPCLNWYSK | 156 | Q9UL63 | |
| LICDPETPDASYLWL | 166 | Q00889 | |
| TLDDDKPWYSIFPID | 476 | Q8IZX4 | |
| TYGSLDEEDLKCLPW | 301 | Q5SWL8 | |
| DEEDLKCLPWYPSLS | 306 | Q5SWL8 | |
| SLTCDPETPDASYLW | 166 | Q9UQ74 | |
| LEKSWSQYLACPEDI | 671 | O00291 | |
| PEAAWLSDCYLLLAD | 701 | Q8TE82 | |
| LGPWERPTELCLETY | 16 | Q8NAX2 | |
| ILTCDPETPDASYLW | 166 | Q13046 | |
| CWPELSALIDYDLQI | 21 | A0A1B0GUA7 | |
| IPVETLTPEIALYWC | 326 | Q9BPX3 | |
| GPVCDLLWSDPSEDY | 221 | P48454 | |
| SPLCQWLYLEAADIV | 411 | A0AVT1 | |
| IFYVLPLKSEDPCNW | 261 | Q6XR72 | |
| LSLDLEQCIPFWPEY | 2336 | Q96RL7 | |
| EQCIPFWPEYASSKL | 2341 | Q96RL7 | |
| ESSDALPEWPVLYCE | 386 | Q9NXB0 | |
| LPEWPVLYCEVLSLD | 391 | Q9NXB0 | |
| YRHSWPENLACEELP | 126 | Q92765 | |
| LDLQPVTYSEPAFWC | 261 | Q15796 | |
| LDYTIEIPDQPCWSQ | 6 | Q6P2H8 | |
| LCVAWSPLDPDCIYS | 686 | Q8TEQ6 | |
| ELYVSVQWPCIPDLD | 246 | O60809 | |
| TTCEALTEWEYLPPV | 1536 | O00507 | |
| NPWCPEDAVYLDSEP | 141 | O43548 | |
| LKYPLNCSDPTSERW | 96 | P29350 | |
| PISEEEQIYPWDTCA | 1276 | Q6ZT12 | |
| PGKTLPEALDYCTVW | 1996 | Q7Z7G8 | |
| PEALDYCTVWLQTVP | 2001 | Q7Z7G8 | |
| VTNPYPCEEWRSVED | 476 | P35968 | |
| ILTCDPETPDTSYQW | 166 | P11465 | |
| CDWLRVNESYFKPSP | 576 | Q13395 | |
| CLSNWPEDTDVLYIV | 731 | Q86UV5 | |
| TPSWDLEQKYCPDNL | 311 | O95801 | |
| GDSPVFWYAPECLKE | 1061 | P29597 | |
| RLLYVPPTWTYECDE | 206 | Q5T447 | |
| CYWRDPIPEVDLDDL | 881 | Q92539 | |
| LDDGSPCTDWYQELP | 326 | Q86W25 | |
| PCTDWYQELPVTKIL | 331 | Q86W25 | |
| SSDCKEGVILPIWYP | 51 | P57103 | |
| LYSQCTRVWIPDPDE | 6 | Q9ULV0 |